The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet? Article uri icon

Overview

publication date

  • December 18, 2017

Research

keywords

  • Immunoconjugates
  • Ki-1 Antigen

Identity

Scopus Document Identifier

  • 85038077725

Digital Object Identifier (DOI)

  • 10.1111/bjd.16052

PubMed ID

  • 29023638

Additional Document Info

volume

  • 178

issue

  • 2